137 related articles for article (PubMed ID: 26983700)
1. Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.
Peroja P; Haapasaari KM; Mannisto S; Miinalainen I; Koivunen P; Leppä S; Karjalainen-Lindsberg ML; Kuusisto ME; Turpeenniemi-Hujanen T; Kuittinen O; Karihtala P
Virchows Arch; 2016 May; 468(5):623-30. PubMed ID: 26983700
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas.
Bur H; Haapasaari KM; Turpeenniemi-Hujanen T; Kuittinen O; Auvinen P; Marin K; Koivunen P; Sormunen R; Soini Y; Karihtala P
Histopathology; 2014 Sep; 65(3):319-27. PubMed ID: 24698430
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
[TBL] [Abstract][Full Text] [Related]
4. Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Anticancer Res; 2016 Jan; 36(1):427-33. PubMed ID: 26722077
[TBL] [Abstract][Full Text] [Related]
5. High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.
Kuusisto ME; Haapasaari KM; Turpeenniemi-Hujanen T; Jantunen E; Soini Y; Peroja P; Bloigu R; Karihtala P; Kuittinen O
J Clin Pathol; 2015 Jul; 68(7):552-6. PubMed ID: 25935550
[TBL] [Abstract][Full Text] [Related]
6. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
[TBL] [Abstract][Full Text] [Related]
7. Peroxiredoxins in breast carcinoma.
Karihtala P; Mäntyniemi A; Kang SW; Kinnula VL; Soini Y
Clin Cancer Res; 2003 Aug; 9(9):3418-24. PubMed ID: 12960131
[TBL] [Abstract][Full Text] [Related]
8. Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress.
Lehtonen ST; Markkanen PM; Peltoniemi M; Kang SW; Kinnula VL
Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L997-1001. PubMed ID: 15626747
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.
Nordfors K; Haapasalo J; Helén P; Paetau A; Paljärvi L; Kalimo H; Kinnula VL; Soini Y; Haapasalo H
Clin Neuropathol; 2007; 26(5):210-8. PubMed ID: 17907597
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis.
Madrigal-Matute J; Fernandez-Garcia CE; Blanco-Colio LM; Burillo E; Fortuño A; Martinez-Pinna R; Llamas-Granda P; Beloqui O; Egido J; Zalba G; Martin-Ventura JL
Free Radic Biol Med; 2015 Sep; 86():352-61. PubMed ID: 26117319
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxins and their expression in ependymomas.
Haapasalo T; Nordfors K; Järvelä S; Kok E; Sallinen P; Kinnula VL; Haapasalo HK; Soini Y
J Clin Pathol; 2013 Jan; 66(1):12-7. PubMed ID: 23076395
[TBL] [Abstract][Full Text] [Related]
12. Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues.
Kim HJ; Chae HZ; Kim YJ; Kim YH; Hwangs TS; Park EM; Park YM
Cell Biol Toxicol; 2003 Oct; 19(5):285-98. PubMed ID: 14703116
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide.
Pannala VR; Dash RK
Free Radic Biol Med; 2015 Jan; 78():42-55. PubMed ID: 25451645
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung.
Park JH; Kim YS; Lee HL; Shim JY; Lee KS; Oh YJ; Shin SS; Choi YH; Park KJ; Park RW; Hwang SC
Respirology; 2006 May; 11(3):269-75. PubMed ID: 16635084
[TBL] [Abstract][Full Text] [Related]
15. Broad specificity AhpC-like peroxiredoxin and its thioredoxin reductant in the sparse antioxidant defense system of Treponema pallidum.
Parsonage D; Desrosiers DC; Hazlett KR; Sun Y; Nelson KJ; Cox DL; Radolf JD; Poole LB
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6240-5. PubMed ID: 20304799
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling.
Cox AG; Winterbourn CC; Hampton MB
Biochem J; 2009 Dec; 425(2):313-25. PubMed ID: 20025614
[TBL] [Abstract][Full Text] [Related]
17. An antioxidant redox system in the nucleus of wheat seed cells suffering oxidative stress.
Pulido P; Cazalis R; Cejudo FJ
Plant J; 2009 Jan; 57(1):132-45. PubMed ID: 18786001
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.
Ow SH; Chua PJ; Bay BH
Exp Biol Med (Maywood); 2017 Jan; 242(2):140-147. PubMed ID: 27633575
[TBL] [Abstract][Full Text] [Related]
19. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2).
Smith-Pearson PS; Kooshki M; Spitz DR; Poole LB; Zhao W; Robbins ME
Free Radic Biol Med; 2008 Oct; 45(8):1178-89. PubMed ID: 18718523
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.
Pylväs M; Puistola U; Kauppila S; Soini Y; Karihtala P
Eur J Cancer; 2010 Jun; 46(9):1661-7. PubMed ID: 20206498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
